Agilon Health Inc. (AGL) Misses Q2 EPS by 74c

Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of ($0.79), $0.74 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $499 million versus the consensus estimate of $473.29 million.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41